InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Santel Donald J, 董事. Officer active across 3 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 4 filings have been published. History available since 30 July 2021. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Santel Donald J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
5,489 股Common StockSEC:0001209191-23-001092:0
3,573 股0Common StockSEC:0001209191-22-035055:0
30,000 股Common StockSEC:0000899243-21-033041:0
6,937 股0Common StockSEC:0001209191-21-049492:0
4 条申报中的 4 条
About Santel Donald J
Donald J. Santel is a Board Member at Oyster Point Pharma, Inc. and Surrozen, Inc. He contributes to the governance of these companies, bringing his expertise in strategy and management. His role is essential in guiding their development.
